Taro Pharmaceuticals (NYSE:TARO) said it began a voluntary type 1 recall of six lots of bone disorder drug Taro-Zoledronic Acid injection as they may contain particulate matter over the specified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback